Molecular characterization of malignant connective tumors makes it possible to implement targeted therapeutic strategies, such as, for example, mutations that activate KIT and PDGFRA in gastrointestinal stromal tumors

Authors
Florence Duffaud, Hôpital Timone, Marseille, France
Authors
Florence Duffaud, Hôpital Timone, Marseille, France
Category
Oncology
Publication type
Proceedings
Year
2019
Download the publication